Whereas CatS inhibition enhances immunosuppressive activity of Tregs under normal conditions, transfer of CatS inhibitor-treated Tregs into bladder carcinoma MB49 model mice led to reduction in number of splenic and tumor Tregs, and reduction of tumor and splenic cell proliferation compared to control animals (238). Here, PIMREG is linked to urinary bladder carcinoma.